Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

The treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) is frequently characterized by significant toxicity and rapid development of resistance to current approved therapies. More reliable biomarkers of response are needed to guide clinical decision making. We evaluated cell-free DNA (cf...

Descripción completa

Detalles Bibliográficos
Autores principales: Christenson, Eric S., Lim, Su Jin, Durham, Jennifer, De Jesus-Acosta, Ana, Bever, Katherine, Laheru, Daniel, Ryan, Amy, Agarwal, Parul, Scharpf, Robert B., Le, Dung T., Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035498/
https://www.ncbi.nlm.nih.gov/pubmed/36970054
http://dx.doi.org/10.1158/2767-9764.CRC-22-0343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035498/
https://www.ncbi.nlm.nih.gov/pubmed/36970054
http://dx.doi.org/10.1158/2767-9764.CRC-22-0343

Ejemplares similares